METASTATIC PROSTATE CANCER
Clinical trials for METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise in fighting advanced prostate cancer
Disease control Not yet recruitingThis study is testing if adding a common diabetes drug, dapagliflozin, to standard hormone therapy helps control advanced prostate cancer that has spread and stopped responding to standard hormone treatments. It will involve 60 men whose cancer has spread and who are starting a s…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for men with advanced prostate cancer: radioactive drug trial seeks to control disease after other treatments fail
Disease control Not yet recruitingThis trial is testing a new radioactive drug called Actinium rhPSMA-10.1 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The drug is designed to find and destroy prostate cancer cells throughout the body using targeted …
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Radical surgery tested as new hope for men with widespread prostate cancer
Disease control Not yet recruitingThis study is testing whether surgically removing the prostate helps men with advanced prostate cancer that has already spread to other parts of the body. After 6 months of strong hormone-blocking drug therapy, patients whose scans show the cancer has quieted down will be randoml…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New Two-Pronged attack on advanced prostate cancer in the liver
Disease control Not yet recruitingThis early-stage study is testing the safety of combining two treatments for advanced prostate cancer that has spread to the liver. It will give a radioactive drug that targets prostate cancer cells, along with a separate treatment focused directly on the liver tumors. The goal i…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Could a tiny pill fight cancer treatment exhaustion?
Symptom relief Not yet recruitingThis study aims to see if a small daily dose of a medication called naltrexone (LDN) can safely help reduce severe tiredness (fatigue) in men with prostate cancer who are receiving hormone therapy. It will involve 60 men who report significant fatigue. Researchers will measure ch…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Mar 30, 2026 14:27 UTC
-
AI-Powered registry tracks advanced prostate cancer treatment in real life
Knowledge-focused Not yet recruitingThis study aims to understand how a specific treatment for metastatic prostate cancer is used in real-world medical practice. It will observe about 750 patients who have already received the drug, collecting data on their treatment patterns, side effects, and health outcomes. The…
Matched conditions: METASTATIC PROSTATE CANCER
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC